Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey C Barrett

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Clinical Endocrinology|July 15, 2010
Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3Matthew J Simmonds, Oliver J Brand, Jeffrey C Barrett, et al.
Wellcome Open Research|March 21, 2017
Returning genome sequences to research participants: Policy and practiceCaroline F Wright, Anna Middleton, Jeffrey C Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|December 7, 2006
Association of PTPN22 haplotypes with Graves' diseaseJoanne M Heward, Oliver J Brand, Jeffrey C Barrett, et al.
American Journal of Human Genetics|July 1, 2008
Evaluating the effects of imputation on the power, coverage, and cost efficiency of genome-wide SNP platformsCarl A Anderson, Fredrik H Pettersson, Jeffrey C Barrett, et al.
Nature Protocols|April 25, 2009
Marker selection for genetic case-control association studiesFredrik H Pettersson, Carl A Anderson, Geraldine M Clarke, et al.
Gut|June 12, 2012
The intermediate filament protein, vimentin, is a regulator of NOD2 activityCraig Stevens, Paul Henderson, Elaine R Nimmo, et al.
Gastroenterology|July 5, 2016
Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish FamiliesAdam P Levine, Nikolas Pontikos, Elena R Schiff, et al.
Genome Research|June 23, 2019
Exome-wide assessment of the functional impact and pathogenicity of multinucleotide mutationsJoanna Kaplanis, Nadia Akawi, Giuseppe Gallone, et al.
BMC Medical Genetics|May 1, 2015
Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancerSiana N Mtatiro, Josephine Mgaya, Tarjinder Singh, et al.
Nature|March 22, 2018
De novo mutations in regulatory elements in neurodevelopmental disordersPatrick J Short, Jeremy F McRae, Giuseppe Gallone, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Clinical Endocrinology|July 15, 2010
Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3Matthew J Simmonds, Oliver J Brand, Jeffrey C Barrett, et al.
Wellcome Open Research|March 21, 2017
Returning genome sequences to research participants: Policy and practiceCaroline F Wright, Anna Middleton, Jeffrey C Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|December 7, 2006
Association of PTPN22 haplotypes with Graves' diseaseJoanne M Heward, Oliver J Brand, Jeffrey C Barrett, et al.
American Journal of Human Genetics|July 1, 2008
Evaluating the effects of imputation on the power, coverage, and cost efficiency of genome-wide SNP platformsCarl A Anderson, Fredrik H Pettersson, Jeffrey C Barrett, et al.
Nature Protocols|April 25, 2009
Marker selection for genetic case-control association studiesFredrik H Pettersson, Carl A Anderson, Geraldine M Clarke, et al.
Gut|June 12, 2012
The intermediate filament protein, vimentin, is a regulator of NOD2 activityCraig Stevens, Paul Henderson, Elaine R Nimmo, et al.
Gastroenterology|July 5, 2016
Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish FamiliesAdam P Levine, Nikolas Pontikos, Elena R Schiff, et al.
Genome Research|June 23, 2019
Exome-wide assessment of the functional impact and pathogenicity of multinucleotide mutationsJoanna Kaplanis, Nadia Akawi, Giuseppe Gallone, et al.
BMC Medical Genetics|May 1, 2015
Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancerSiana N Mtatiro, Josephine Mgaya, Tarjinder Singh, et al.
Nature|March 22, 2018
De novo mutations in regulatory elements in neurodevelopmental disordersPatrick J Short, Jeremy F McRae, Giuseppe Gallone, et al.
Pageof 11